Time for a new model in patient access
Mig Sleeper, vice president, Global Pricing for Astellas Pharma Europe, explains why we must rethink how value is defined as we enter a new technological era for medicines. Why is a new access model so pressing, and has the pandemic accelerated the situation? Yes, it has. Although the need for a change in the […]